Review: Novel insights on diagnosis, cause and treatment of diabetic neuropathy: Focus on painful diabetic neuropathy

Therapeutic Advances in Endocrinology and Metabolism

Volumn 1, Issue 2, 2010, Pages 69-88

  Tavakoli, Mitra ^a   Asghar, Omar ^a   Alam, Uazman ^a   Petropoulos, Ioannis N ^a   Fadavi, Hassan ^a   Malik, Rayaz A ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

diabetic neuropathy; diagnosis; nonpharmacological treatment; painful diabetic neuropathy; pharmacological

Indexed keywords

ACETYLCYSTEINE; ALDOSE REDUCTASE INHIBITOR; AMITRIPTYLINE; BENFOTIAMINE; CANNABIS; CAPSAICIN; CARBAMAZEPINE; DULOXETINE; EPALRESTAT; GABAPENTIN; GLYCERYL TRINITRATE; IMIPRAMINE; INSULIN; LAMOTRIGINE; LISINOPRIL; MEXILETINE; OXYCODONE; PIOGLITAZONE; PLACEBO; PREGABALIN; RANIRESTAT; RESINIFERATOXIN; THIOCTIC ACID; TRAMADOL; TRANDOLAPRIL; TROGLITAZONE; UNINDEXED DRUG; VALPROIC ACID; VASCULOTROPIN; VENLAFAXINE;

ACUPUNCTURE; AGRANULOCYTOSIS; ALLODYNIA; ANTICHOLINERGIC EFFECT; AXONAL INJURY; CLINICAL ASSESSMENT; CLINICAL TRIAL (TOPIC); CONSTIPATION; DIABETES MELLITUS; DIABETIC NEUROPATHY; DIAGNOSTIC ERROR; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; DISEASE CONTROL; DISEASE SEVERITY; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG MECHANISM; EXERCISE; FOOT EDEMA; GENE TRANSFER; GLYCEMIC CONTROL; HEART ARRHYTHMIA; HUMAN; HYPOGLYCEMIA; LOW LEVEL LASER THERAPY; MAGNETOTHERAPY; METABOLIC DISORDER; MORBIDITY; MORTALITY; NAUSEA; NERVE DECOMPRESSION; NERVE FUNCTION; NEUROPATHIC PAIN; NONHUMAN; OXIDATIVE STRESS; PANCREAS TRANSPLANTATION; PHYSIOTHERAPY; PLACEBO EFFECT; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; PSYCHOTHERAPY; REVIEW; RISK ASSESSMENT; SEDATION; SENSORY NERVE CONDUCTION; SIDE EFFECT; SOMNOLENCE; THERAPY EFFECT; TRANSCUTANEOUS NERVE STIMULATION; TREATMENT DURATION; TREMOR; VIBRATION SENSE;

EID: 78650229065     PISSN: 20420188     EISSN: None     Source Type: Journal    
DOI: 10.1177/2042018810370954     Document Type: Review

References (208)

1. Abbott, C.A., Carrington, A.L., Ashe, H., Bath, S., Every, L.C., Griffiths, J. et al (2002) The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet Med 19: 377-384.
2. Abuaisha, B.B., Costanzi, J.B. and Boulton, A.J. ( 1998) Acupuncture for the treatment of chronic painful peripheral diabetic neuropathy: a long-term study. Diabetes Res Clin Pract 39: 115-121.
3. Agrawal, R.P., Goswami, J., Jain, S. and Kochar, D.K. (2009) Management of diabetic neuropathy by sodium valproate and glyceryl trinitrate spray: A prospective double-blind randomized placebo-controlled study. Diabetes Res Clin Pract 83: 371-378.
4. Aiello, L.P., Avery, R.L., Arrigg, P.G., Keyt, B.A., Jampel, H.D., Shah, S.T. et al (1994) Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331: 1480-1487.
5. Ametov, A.S., Barinov, A., Dyck, P.J., Hermann, R., Kozlova, N., Litchy, W.J. et al (2003) The sensory symptoms of diabetic polyneuropathy are improved with α-lipoic acid. Diabetes Care 26: 770-776.
6. Anderson, R.J., Freedland, K.E., Clouse, R.E. and Lustman, P.J. ( 2001) The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 24: 1069-1078.
7. Andersson, S. and Lundeberg, T. ( 1995) Acupuncture - from empiricism to science: functional background to acupuncture effects in pain and disease. Med Hypotheses 45: 271-281.
8. Andre-Obadia, N., Mertens, P., Gueguen, A., Peyron, R. and Garcia-Larrea, L. ( 2008) Pain relief by rTMS: differential effect of current flow but no specific action on pain subtypes. Neurology 71: 833-840.
9. Armstrong, D.G., Lavery, L.A., Fleischli, J.G. and Gilham, K.A. ( 1997) Is electrical stimulation effective in reducing neuropathic pain in patients with diabetes? J Foot Ankle Surg 36: 260-263.
10. Attal, N., Cruccu, G., Haanpaa, M., Hansson, P., Jensen, T.S., Nurmikko, T. et al (2006) EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 13: 1153-1169.
11. Backonja, M.M., Irving, G. and Argoff, C. ( 2006) Rational multidrug therapy in the treatment of neuropathic pain. Curr Pain Headache Rep 10: 34-38.
12. Baron, R., Mayoral, V., Leijon, G., Binder, A., Steigerwald, I. and Serpell, M. (2009) Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy. Curr Med Res Opin 25: 1677-1687.
13. Bernateck, M., Rolke, R., Birklein, F., Treede, R.D., Fink, M. and Karst, M. ( 2007) Successful intravenous regional block with low-dose tumor necrosis factor-alpha antibody infliximab for treatment of complex regional pain syndrome 1. Anesth Analg 105: 1148-1151, table of contents.
14. Bevilacqua, M., Dominquez, L.J., Barrella, M. and Barbagallo, M. ( 2007) Induction of vascular endothelial growth factor release by transcutaneous frequency modulated neural stimulation in diabetic polyneuropathy. J Endocrinol Invest 30: 944-947.
15. Biesbroeck, R., Bril, V., Hollander, P., Kabadi, U., Schwartz, S., Singh, S.P. et al (1995) A double-blind comparison of topical capsaicin and oral amitriptyline in painful diabetic neuropathy. Adv Ther 12: 111-120.
16. Booth, J. and Young, M.J. ( 2000) Differences in the performance of commercially available 10-g monofilaments. Diabetes Care 23: 984-988.
17. Borckardt, J.J., Smith, A.R., Reeves, S.T., Weinstein, M., Kozel, F.A., Nahas, Z. et al (2007) Fifteen minutes of left prefrontal repetitive transcranial magnetic stimulation acutely increases thermal pain thresholds in healthy adults. Pain Res Manag 12: 287-290.
18. Boucek, P., Havrdova, T., Voska, L., Lodererova, A., Saudek, F., Lipar, K. et al (2005) Severe depletion of intraepidermal nerve fibers in skin biopsies of pancreas transplant recipients. Transplant Proc 37: 3574-3575.
19. Boulton, A.J., Malik, R.A., Arezzo, J.C. and Sosenko, J.M. ( 2004) Diabetic somatic neuropathies. Diabetes Care 27: 1458-1486.
20. Bretin, S., Rogemond, V., Marin, P., Maus, M., Torrens, Y., Honnorat, J. et al (2006) Calpain product of WT-CRMP2 reduces the amount of surface NR2B NMDA receptor subunit. J Neurochem 98: 1252-1265.
21. Bril, V. and Buchanan, R. ( 2004) Aldose reductase inhibition by AS-3201 in sural nerve from patients with diabetic sensorimotor polyneuropathy. Diabetes Care 27: 2369-2375.
22. Bril, V. and Buchanan, R.A. ( 2006) Long-term effects of ranirestat (AS-3201) on peripheral nerve function in patients with diabetic sensorimotor polyneuropathy. Diabetes Care 29: 68-72.
23. Bril, V., Toshiyuki, H., Tomioka, S. and Buchanan, R. (2009) Ranirestat for the management of diabetic sensorimotor polyneuropathy. Diabetes Care 32: 1256-1260.
24. Calcutt, N.A. and Backonja, M.M. ( 2007) Pathogenesis of pain in peripheral diabetic neuropathy. Curr Diab Rep 7: 429-434.
25. Carmeliet, P. ( 2003) Angiogenesis in health and disease. Nature Med 9: 653-660.
26. Carroll, I.R., Kaplan, K.M. and Mackey, S.C. ( 2008) Mexiletine therapy for chronic pain: survival analysis identifies factors predicting clinical success. J Pain Symptom Manage 35: 321-326.
27. Casellini, C.M., Barlow, P.M., Rice, A.L., Casey, M., Simmons, K., Pittenger, G. et al (2007) A 6-month, randomized, double-masked, placebo-controlled study evaluating the effects of the protein kinase C-beta inhibitor ruboxistaurin on skin microvascular blood flow and other measures of diabetic peripheral neuropathy. Diabetes Care 30: 896-902.
28. Chalk, C., Benstead, T. and Moore, F. ( 2007) Aldose reductase inhibitors for the treatment of diabetic polyneuropathy (Review). The Cochrane Library 4: 1-46.
29. Challapalli, V., Tremont-Lukats, I.W., McNicol, E.D., Lau, J. and Carr, D.B. ( 2005) Systemic administration of local anesthetic agents to relieve neuropathic pain. Cochrane Database Syst Rev 4: CD003345.
30. Chattopadhyay, M., Mata, M. and Fink, D.J. ( 2008) Continuous delta-opioid receptor activation reduces neuronal voltage-gated sodium channel (NaV1.7) levels through activation of protein kinase C in painful diabetic neuropathy. J Neurosci 28: 6652-6658.
31. Chaudhry, V., Stevens, J.C., Kincaid, J. and So, Y.T. ( 2006) Practice Advisory: utility of surgical decompression for treatment of diabetic neuropathy: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 66: 1805-1808.
32. Chizh, B.A., O'Donnell, M.B., Napolitano, A., Wang, J., Brooke, A.C., Aylott, M.C. et al (2007) The effects of the TRPV 1 antagonist SB-705498 on TRPV 1 receptor-mediated activity and inflammatory hyperalgesia in humans. Pain 132: 132-141.
33. Choi, J.S., Zhang, L., Dib-Hajj, S.D., Han, C., Tyrrell, L., Lin, Z. et al (2009) Mexiletine-responsive erythromelalgia due to a new Na(v)1.7 mutation showing use-dependent current fall-off. Exp Neurol 216: 383-389.
34. Chong, M.S. and Hester, J. ( 2007) Diabetic painful neuropathy: current and future treatment options. Drugs 67: 569-585.
35. Chow, R.T., Johnson, M.I., Lopes-Martins, R.A. and Bjordal, J.M. (2009) Efficacy of low-level laser therapy in the management of neck pain: a systematic review and meta-analysis of randomised placebo or active-treatment controlled trials. Lancet 374: 1897-1908.
36. Christoph, T., Bahrenberg, G., de Vry, J., Englberger, W., Erdmann, V.A., Frech, M. et al (2008) Investigation of TRPV 1 loss-of-function phenotypes in transgenic shRNA expressing and knockout mice. Mol Cell Neurosci 37: 579-589.
37. Colbert, A.P., Wahbeh, H., Harling, N., Connelly, E., Schiffke, H.C., Forsten, C. et al (2009) Static magnetic field therapy: a critical review of treatment parameters. Evid Based Complement Alternat Med 6: 133-139.
38. Conti, M., Peretti, E., Cazzetta, G., Galimberti, G., Vermigli, C., Pola, R. et al (2009) Frequency-modulated electromagnetic neural stimulation enhances cutaneous microvascular flow in patients with diabetic neuropathy. J Diabetes Complications 23: 46-48.
39. Daousi, C., Benbow, S.J. and MacFarlane, I.A. ( 2005) Electrical spinal cord stimulation in the long-term treatment of chronic painful diabetic neuropathy. Diabet Med 22: 393-398.
40. de Leeuw, K., Kusumanto, Y., Smit, A.J., Oomen, P., van der Hoeven, J.H., Mulder, N.H. et al (2008) Skin capillary permeability in the diabetic foot with critical limb ischaemia: the effects of a phVEGF 165 gene product. Diabet Med 25: 1241-1244.
41. Deguchi, T., Hashiguchi, T., Horinouchi, S., Uto, T., Oku, H., Kimura, K. et al (2009) Serum VEGF increases in diabetic polyneuropathy, particularly in the neurologically active symptomatic stage. Diabet Med 26: 247-252.
42. DeLellis, S.L., Carnegie, D.H. and Burke, T.J. ( 2005) Improved sensitivity in patients with peripheral neuropathy: effects of monochromatic infrared photo energy. J Am Podiatr Med Assoc 95: 143-147.
43. Demiot, C., Fromy, B., Saumet, J.L. and Sigaudo-Roussel, D. ( 2006) Preservation of pressure-induced cutaneous vasodilation by limiting oxidative stress in short-term diabetic mice. Cardiovasc Res 69: 245-252.
44. Dib-Hajj, S.D., Binshtok, A.M., Cummins, T.R., Jarvis, M.F., Samad, T. and Zimmermann, K. (2009 a) Voltage-gated sodium channels in pain states: role in pathophysiology and targets for treatment. Brain Res Rev 60: 65-83.
45. Dib-Hajj, S.D., Black, J.A. and Waxman, S.G. (2009 b) Voltage-gated sodium channels: therapeutic targets for pain. Pain Med 10: 1260-1269.
46. Du, X., Edelstein, D. and Brownlee, M. ( 2008) Oral benfotiamine plus α-lipoic acid normalises complication-causing pathways in type 1 diabetes. Diabetologia 51: 1930-1932.
47. Dubinsky, R.M. and Miyasaki, J. (2010) Assessment: efficacy of transcutaneous electric nerve stimulation in the treatment of pain in neurologic disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 74: 173-176.
48. Dworkin, R.H., Katz, J. and Gitlin, M.J. ( 2005) Placebo response in clinical trials of depression and its implications for research on chronic neuropathic pain. Neurology 65(12 Suppl 4): S7-S19.
49. Dworkin, R.H., O'Connor, A.B., Backonja, M., Farrar, J.T., Finnerup, N.B., Jensen, T.S. et al (2007) Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 132: 237-251.
50. Dyck, P.J., Norell, J.E., Tritschler, H., Schuette, K., Samigullin, R., Ziegler, D. et al (2007) Challenges in design of multicenter trials: end points assessed longitudinally for change and monotonicity. Diabetes Care 30: 2619-2625.
51. Egede, L.E., Zheng, D. and Simpson, K. ( 2002) Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care 25: 464-470.
52. Errington, A.C., Stohr, T., Heers, C. and Lees, G. ( 2008) The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels. Mol Pharmacol 73: 157-169.
53. Eshkevari, L. ( 2003) Acupuncture and pain: a review of the literature. AANA J 71: 361-370.
54. Eshkevari, L. and Heath, J. ( 2005) Use of acupuncture for chronic pain: optimizing clinical practice. Holist Nurs Pract 19: 217-221.
55. Estacion, M., Harty, T.P., Choi, J.S., Tyrrell, L., Dib-Hajj, S.D. and Waxman, S.G. ( 2009) A sodium channel gene SCN9A polymorphism that increases nociceptor excitability. Ann Neurol 66: 862-866.
56. Evans, J.L., Heymann, C.J., Ira, D. and Gavin, L.A. ( 2002) Pharmacokinetics, tolerability, and fructosamine-lowering effect of a novel, controlled-release formulation of alpha-lipoic acid. Endocrine Pract 8: 29-35.
57. Faghihi, H., Roohipoor, R., Mohammadi, S.F., Hojat-Jalali, K., Mirshahi, A., Lashay, A. et al (2008) Intravitreal bevacizumab versus combined bevacizumab-triamcinolone versus macular laser photocoagulation in diabetic macular edema. Eur J Ophthalmol 18: 941-948.
58. Faivre, A., Franques, J., de Paula, A.M., Gutierrez, M., Bret, S., Aubert, S. et al (2010) Acute motor and sensory axonal neuropathy and concomitant encephalopathy during tumor necrosis factor-alpha antagonist therapy. J Neurol Sci 291(1-2): 103-106.
59. Fischer, T.Z., Gilmore, E.S., Estacion, M., Eastman, E., Taylor, S., Melanson, M. et al (2009) A novel Nav1.7 mutation producing carbamazepine-responsive erythromelalgia. Ann Neurol 65: 733-741.
60. Forst, T., Nguyen, M., Forst, S., Disselhoff, B., Pohlmann, T. and Pfutzner, A. ( 2004) Impact of low frequency transcutaneous electrical nerve stimulation on symptomatic diabetic neuropathy using the new Salutaris device. Diabetes Nutr Metab 17: 163-168.
61. Foster, A.V., Eaton, C., McConville, D.O. and Edmonds, M.E. ( 1994) Application of OpSite film: a new and effective treatment of painful diabetic neuropathy. Diabet Med 11: 768-772.
62. Freeman, R., Durso-Decruz, E. and Emir, B. ( 2008) Efficacy, safety, and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy: findings from seven randomized, controlled trials across a range of doses. Diabetes Care 31: 1448-1454.
63. Freeman, R., Raskin, P., Hewitt, D.J., Vorsanger, G.J., Jordan, D.M., Xiang, J. et al (2007) Randomized study of tramadol/acetaminophen versus placebo in painful diabetic peripheral neuropathy. Curr Med Res Opin 23: 147-161.
64. Fromy, B., Abraham, P., Bouvet, C., Bouhanick, B., Fressinaud, P. and Saumet, J.L. ( 2002) Early decrease of skin blood flow in response to locally applied pressure in diabetic subjects. Diabetes 51: 1214-1217.
65. Galiano, R.D., Tepper, O.M., Pelo, C.R., Bhatt, K.A., Callaghan, M., Bastidas, N. et al (2004) Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells. Am J Pathol 164: 1935-1947.
66. Gavva, N.R., Treanor, J.J., Garami, A., Fang, L., Surapaneni, S., Akrami, A. et al (2008) Pharmacological blockade of the vanilloid receptor TRPV 1 elicits marked hyperthermia in humans. Pain 136: 202-210.
67. Gianturco, V., Bellomo, A., D'Ottavio, E., Formosa, V., Iori, A., Mancinella, M. et al (2009) Impact of therapy with alpha-lipoic acid (ALA) on the oxidative stress in the controlled NIDDM: a possible preventive way against the organ dysfunction? Arch Gerontol Geriatr 49: 129-133.
68. Gilbert, R.E., Vranes, D., Berka, J.L., Kelly, D.J., Cox, A., Wu, L.L. et al (1998) Vascular endothelial growth factor and its receptors in control and diabetic rat eyes. Lab Invest 78: 1017-1027.
69. Goldberg, N. ( 2005) Monochromatic infrared photo energy and DPN. Diabetic Microvasc Complications Today March/April: 30-32.
70. Goldstein, D.J., Lu, Y., Detke, M.J., Lee, T.C. and Iyengar, S. ( 2005) Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 116: 109-118.
71. Gore, M., Dukes, E., Rowbotham, D.J., Tai, K.S. and Leslie, D. ( 2007) Clinical characteristics and pain management among patients with painful peripheral neuropathic disorders in general practice settings. Eur J Pain 11: 652-664.
72. Green, A.Q., Krishnan, S., Finucane, F.M. and Rayman, G. ( 2010) Altered C-fiber function as an indicator of early peripheral neuropathy in individuals with impaired glucose tolerance. Diabetes Care 33: 174-176.
73. Greenstein, A.S., Khavandi, K., Withers, S.B., Sonoyama, K., Clancy, O., Jeziorska, M. et al (2009) Local inflammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patients. Circulation 119: 1661-1670.
74. Hamada, Y. and Nakamura, J. ( 2004) Clinical potential of aldose reductase inhibitors in diabetic neuropathy. Treat Endocrinol 3: 245-255.
75. Hamza, M.A., White, P.F., Craig, W.F., Ghoname, E.S., Ahmed, H.E., Proctor, T.J. et al (2000) Percutaneous electrical nerve stimulation: a novel analgesic therapy for diabetic neuropathic pain. Diabetes Care 23: 365-370.
76. Han, C., Dib-Hajj, S.D., Lin, Z., Li, Y., Eastman, E.M., Tyrrell, L. et al (2009) Early- and late-onset inherited erythromelalgia: genotype-phenotype correlation. Brain 132(Pt 7): 1711-1722.
77. Han, J.S. ( 2004) Acupuncture and endorphins. Neurosci Lett 361: 258-261.
78. Hanna, M., O'Brien, C. and Wilson, M.C. ( 2008) Prolonged-release oxycodone enhances the effects of existing gabapentin therapy in painful diabetic neuropathy patients. Eur J Pain 12: 804-813.
79. Harkless, L.B., DeLellis, S., Carnegie, D.H. and Burke, T.J. ( 2006) Improved foot sensitivity and pain reduction in patients with peripheral neuropathy after treatment with monochromatic infrared photo energy - MIRE. J Diabetes Complications 20: 81-87.
80. Honda, K., Koguchi, M., Koga, K., Nakajima, K., Kobayashi, F., Migita, K. et al (2007) Contribution of Ca(2+) -dependent protein kinase C in the spinal cord to the development of mechanical allodynia in diabetic mice. Biol Pharm Bull 30: 990-993.
81. Hossain, P., Sachdev, A. and Malik, R.A. ( 2005) Early detection of diabetic peripheral neuropathy with corneal confocal microscopy. Lancet 366: 1340-1343.
82. Hotta, N., Akanuma, Y., Kawamori, R., Matsuoka, K., Oka, Y., Shichiri, M. et al (2006) Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy. Diabetes Care 29: 1538-1544.
83. Hotta, N., Sakamoto, N., Shigeta, Y., Kikkawa, R. and Goto, Y. ( 1996) Clinical investigation of epalrestat, an aldose reductase inhibitor, on diabetic neuropathy in Japan: Multicenter study. J Diabetes Complications 10: 168-172.
84. Hsu, D.T. ( 1996) Acupuncture. A review. Reg Anesth 21: 361-370.
85. Huang, E.A. and Gitelman, S.E. ( 2008) The effect of oral alpha-lipoic acid on oxidative stress in adolescents with type 1 diabetes mellitus. Pediatric Diabetes 9: 69-73.
86. Hung, J.W., Liou, C.W., Wang, P.W., Yeh, S.H., Lin, L.W., Lo, S.K. et al (2009) Effect of 12-week tai chi chuan exercise on peripheral nerve modulation in patients with type 2 diabetes mellitus. J Rehabil Med 41: 924-929.
87. Irizarry, M.C.M., Webb, D.J.M., Ali, Z.P., Chizh, B.A.M., Gold, M.M.S.M.D., Kinrade, F.J.B. et al (2009) Predictors of placebo response in pooled lamotrigine neuropathic pain clinical trials. Clin J Pain 25: 469-476.
88. Ishida, S., Usui, T., Yamashiro, K., Kaji, Y., Ahmed, E., Carrasquillo, K.G. et al (2003) VEGF 164 is proinflammatory in the diabetic retina. Invest Ophthalmol Vis Sci 44: 2155-2162.
89. Jain, S.C., Uppal, A., Bhatnagar, S.O. and Talukdar, B. ( 1993) A study of response pattern of non-insulin dependent diabetics to yoga therapy. Diabetes Res Clin Pract 19: 69-74.
90. Jiang, H., Shi, K., Li, X., Zhou, W. and Cao, Y. ( 2006) Clinical study on the wrist-ankle acupuncture treatment for 30 cases of diabetic peripheral neuritis. J Tradit Chin Med 26: 8-12.
91. Joshi, S.K., Honore, P., Hernandez, G., Schmidt, R., Gomtsyan, A., Scanio, M. et al (2009) Additive antinociceptive effects of the selective Nav1.8 blocker A-803467 and selective TRPV 1 antagonists in rat inflammatory and neuropathic pain models. J Pain 10: 306-315.
92. Kamei, J., Mizoguchi, H., Narita, M. and Tseng, L.F. ( 2001) Therapeutic potential of PKC inhibitors in painful diabetic neuropathy. Expert Opin Investig Drugs 10: 1653-1664.
93. Katsuki, A., Sumida, Y., Murashima, S., Murata, K., Takarada, Y., Ito, K. et al (1998) Serum levels of tumor necrosis factor-alpha are increased in obese patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 83: 859-862.
94. Katz, J., Finnerup, N.B. and Dworkin, R.H. ( 2008) Clinical trial outcome in neuropathic pain: Relationship to study characteristics. Neurology 70: 263-272.
95. Kawai, T., Takei, I., Tokui, M., Funae, O., Miyamoto, K., Tabata, M. et al (2009) Effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy in patients with type 2 diabetes, in relation to suppression of N[var epsilon]-carboxymethyl lysine. J Diabetes Complications, in press.
96. Kelly, K.G., Cook, T. and Backonja, M.M. ( 2005) Pain ratings at the thresholds are necessary for interpretation of quantitative sensory testing. Muscle Nerve 32: 179-184.
97. Khedr, E.M., Kotb, H., Kamel, N.F., Ahmed, M.A., Sadek, R. and Rothwell, J.C. ( 2005) Longlasting antalgic effects of daily sessions of repetitive transcranial magnetic stimulation in central and peripheral neuropathic pain. J Neurol Neurosurg Psychiatry 76: 833-838.
98. Knotkova, H., Pappagallo, M. and Szallasi, A. ( 2008) Capsaicin (TRPV1 Agonist) therapy for pain relief: farewell or revival? Clin J Pain 24: 142-154.
99. Kumar, D. and Marshall, H.J. ( 1997) Diabetic peripheral neuropathy: amelioration of pain with transcutaneous electrostimulation. Diabetes Care 20: 1702-1705.
100. Kumar, K., Malik, S. and Demeria, D. ( 2002) Treatment of chronic pain with spinal cord stimulation versus alternative therapies: cost-effectiveness analysis. Neurosurgery 51: 106-115, discussion 115-106.
101. Kuwabara, S. and Misawa, S. ( 2008) Pharmacologic intervention in axonal excitability: in vivo assessment of nodal persistent sodium currents in human neuropathies. Curr Mol Pharmacol 1: 61-67.
102. Lee, H.J., Lee, J.H., Lee, E.O., Kim, K.H., Lee, K.S., Lee, C.H. et al (2009) Substance P and beta endorphin mediate electroacupuncture induced analgesic activity in mouse cancer pain model. Acupunct Electrother Res 34: 27-40.
103. Leonard, D.R., Farooqi, M.H. and Myers, S. ( 2004) Restoration of sensation, reduced pain, and improved balance in subjects with diabetic peripheral neuropathy: a double-blind, randomized, placebo-controlled study with monochromatic near-infrared treatment. Diabetes Care 27: 168-172.
104. Liu, L., Zhao, S.P., Wen, T., Zhou, H.N., Hu, M. and Li, J.X. ( 2008) Postprandial hypertriglyceridemia associated with inflammatory response and procoagulant state after a high-fat meal in hypertensive patients. Coron Artery Dis 19: 145-151.
105. Loseth, S., Stalberg, E., Jorde, R. and Mellgren, S.I. ( 2008) Early diabetic neuropathy: thermal thresholds and intraepidermal nerve fibre density in patients with normal nerve conduction studies. J Neurol 255: 1197-1202.
106. Ma, W. and Quirion, R. ( 2006) Targeting invading macrophage-derived PGE2, IL-6 and calcitonin gene-related peptide in injured nerve to treat neuropathic pain. Expert Opin Ther Targets 10: 533-546.
107. Madej, A., Buldak, L., Basiak, M., Szkrobka, W., Dulawa, A. and Okopien, B. (2009) The effects of 1 month antihypertensive treatment with perindopril, bisoprolol or both on the ex vivo ability of monocytes to secrete inflammatory cytokines. Int J Clin Pharmacol Ther 47: 686-694.
108. Malhotra, V., Singh, S., Tandon, O.P., Madhu, S.V., Prasad, A. and Sharma, S.B. ( 2002) Effect of Yoga asanas on nerve conduction in type 2 diabetes. Indian J Physiol Pharmacol 46: 298-306.
109. Malik, R.A., Tesfaye, S., Newrick, P.G., Walker, D., Rajbhandari, S.M., Siddique, I. et al (2005) Sural nerve pathology in diabetic patients with minimal but progressive neuropathy. Diabetologia 48: 578-585.
110. Malik, R.A., Veves, A., Walker, D., Siddique, I., Lye, R.H., Schady, W. et al (2001) Sural nerve fibre pathology in diabetic patients with mild neuropathy: relationship to pain, quantitative sensory testing and peripheral nerve electrophysiology. Acta Neuropathol 101: 367-374.
111. Malik, R.A., Williamson, S., Abbott, C., Carrington, A.L., Iqbal, J., Schady, W. et al (1998) Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: randomised double-blind controlled trial. Lancet 352: 1978-1981.
112. Mason, L., Moore, R.A., Derry, S., Edwards, J.E. and McQuay, H.J. ( 2004) Systematic review of topical capsaicin for the treatment of chronic pain. BMJ 328: 991.
113. Max, M.B., Lynch, S.A., Muir, J., Shoaf, S.E., Smoller, B. and Dubner, R. ( 1992) Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 326: 1250-1256.
114. McQuay, H.J. ( 2008) Placebo and control event rate, In: McQuay, H.J. et al (eds). Systematic Reviews in Pain Research: Methodology Redefined, IASP Press : Seattle, WA, pp. 51-56.
115. Mehra, S., Tavakoli, M., Kallinikos, P.A., Efron, N., Boulton, A.J., Augustine, T. et al (2007) Corneal confocal microscopy detects early nerve regeneration after pancreas transplantation in patients with type 1 diabetes. Diabetes Care 30: 2608-2612.
116. Miranda-Palma, B., Sosenko, J.M., Bowker, J.H., Mizel, M.S. and Boulton, A.J. ( 2005) A comparison of the monofilament with other testing modalities for foot ulcer susceptibility. Diabetes Res Clin Pract 70: 8-12.
117. Mirshahi, A., Roohipoor, R., Lashay, A., Mohammadi, S.F., Abdoallahi, A. and Faghihi, H. ( 2008) Bevacizumab-augmented retinal laser photocoagulation in proliferative diabetic retinopathy: a randomized double-masked clinical trial. Eur J Ophthalmol 18: 263-269.
118. Misawa, S., Kuwabara, S., Kanai, K., Tamura, N., Nakata, M., Sawai, S. et al (2006) Aldose reductase inhibition alters nodal Na+ currents and nerve conduction in human diabetics. Neurology 66: 1545-1549.
119. Mojaddidi, M., Quattrini, C., Tavakoli, M. and Malik, R.A. ( 2005) Recent developments in the assessment of efficacy in clinical trials of diabetic neuropathy. Curr Diab Rep 5: 417-422.
120. Moore, R.A., Straube, S., Wiffen, P.J., Derry, S. and McQuay, H.J. ( 2009) Pregabalin for acute and chronic pain in adults. Cochrane Database Syst Rev CD007076.
121. Nayak, N.N. and Shankar, K. ( 2004) Yoga: a therapeutic approach. Phys Med Rehabil Clin N Am 15: 783-798, vi.
122. Nicholson, B.P. and Schachat, A.P. ( 2010) A review of clinical trials of anti-VEGF agents for diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol.
123. Noble, M., Treadwell, J.R., Tregear, S.J., Coates, V.H., Wiffen, P.J., Akafomo, C. et al (2010) Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev 1: CD006605.
124. Norcini, M., Vivoli, E., Galeotti, N., Bianchi, E., Bartolini, A. and Ghelardini, C. (2009) Supraspinal role of protein kinase C in oxaliplatin-induced neuropathy in rat. Pain 146: 141-147.
125. Oates, P.J. ( 2008) Aldose reductase, still a compelling target for diabetic neuropathy. Curr Drug Targets 9: 14-36.
126. Orr, R., Tsang, T., Lam, P., Comino, E. and Singh, M.F. ( 2006) Mobility impairment in type 2 diabetes: association with muscle power and effect of Tai Chi intervention. Diabetes Care 29: 2120-2122.
127. Pawson, E.J., Duran-Jimenez, B., Surosky, R., Brooke, H.E., Spratt, S.K., Tomlinson, D.R. et al (2009) Engineered zinc finger protein mediated VEGF-A activation restores deficient VEGF-A in sensory neurons in experimental diabetes. Diabetes.
128. Polydefkis, M., Hauer, P., Sheth, S., Sirdofsky, M., Griffin, J.W. and McArthur, J.C. ( 2004) The time course of epidermal nerve fibre regeneration: studies in normal controls and in people with diabetes, with and without neuropathy. Brain 127: 1606-1615.
129. Prendergast, J.J., Miranda, G. and Sanchez, M. ( 2004) Improvement of sensory impairment in patients with peripheral neuropathy. Endocr Pract 10: 24-30.
130. Price, S.A., Dent, C., Duran-Jimenez, B., Liang, Y., Zhang, L., Rebar, E.J. et al (2006) Gene transfer of an engineered transcription factor promoting expression of VEGF-A protects against experimental diabetic neuropathy. Diabetes 55: 1847-1854.
131. Qiang, X., Satoh, J., Sagara, M., Fukuzawa, M., Masuda, T., Miyaguchi, S. et al (1998 a) Gliclazide inhibits diabetic neuropathy irrespective of blood glucose levels in streptozotocin-induced diabetic rats. Metabolism 47: 977-981.
132. Qiang, X., Satoh, J., Sagara, M., Fukuzawa, M., Masuda, T., Sakata, Y. et al (1998 b) Inhibitory effect of troglitazone on diabetic neuropathy in streptozotocin-induced diabetic rats. Diabetologia 41: 1321-1326.
133. Quattrini, C., Jeziorska, M., Boulton, A.J. and Malik, R.A. ( 2008) Reduced vascular endothelial growth factor expression and intra-epidermal nerve fiber loss in human diabetic neuropathy. Diabetes Care 31: 140-145.
134. Quattrini, C., Tavakoli, M., Jeziorska, M., Kallinikos, P., Tesfaye, S., Finnigan, J. et al (2007) Surrogate markers of small fiber damage in human diabetic neuropathy. Diabetes 56: 2148-2154.
135. Quessy, S.N. and Rowbotham, M.C. ( 2008) Placebo response in neuropathic pain trials. Pain 138: 479-483.
136. Ramirez, M.A. and Borja, N.L. ( 2008) Epalrestat: an aldose reductase inhibitor for the treatment of diabetic neuropathy. Pharmacotherapy 28: 646-655.
137. Rappaport, B.A. ( 2007) Current FDA policy on analgesic drug and biologic products development. In: 10th International Conference on the Mechanisms and Treatment of Neuropathic Pain.
138. Raskin, J., Wang, F., Pritchett, Y.L. and Goldstein, D.J. ( 2006) Duloxetine for patients with diabetic peripheral neuropathic pain: a 6-month open-label safety study. Pain Medicine 7: 373-385.
139. Rauck, R.L.M., Shaibani, A.M.D., Biton, V.M.D., Simpson, J.P. and Koch, B.P. ( 2007) Lacosamide in painful diabetic peripheral neuropathy: a phase 2 double-blind placebo-controlled study. Clin J Pain 23: 150-158.
140. Reja, A., Tesfaye, S., Harris, N.D. and Ward, J.D. ( 1995) Is ACE inhibition with lisinopril helpful in diabetic neuropathy? Diabet Med 12: 307-309.
141. Ropper, A.H., Gorson, K.C., Gooch, C.L., Weinberg, D.H., Pieczek, A., Ware, J.H. et al (2009) Vascular endothelial growth factor gene transfer for diabetic polyneuropathy: a randomized, double-blinded trial. Ann Neurol 65: 386-393.
142. Rowbotham, M.C., Goli, V., Kunz, N.R. and Lei, D. ( 2004) Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study. Pain 110: 697-706.
143. Sagara, M., Satoh, J., Wada, R., Yagihashi, S., Takahashi, K., Fukuzawa, M. et al (1996) Inhibition of development of peripheral neuropathy in streptozotocin-induced diabetic rats with N-acetylcysteine. Diabetologia 39: 263-269.
144. Sahin, S., Karsidag, S., Ayalp, S., Sengul, A., Us, O. and Karsidag, K. ( 2009) Determination of nerve conduction abnormalities in patients with impaired glucose tolerance. Neurol Sci.
145. Samii, A., Unger, J. and Lange, W. ( 1999) Vascular endothelial growth factor expression in peripheral nerves and dorsal root ganglia in diabetic neuropathy in rats. Neurosci Lett 262: 159-162.
146. Satoh, J., Yagihashi, S. and Toyota, T. ( 2003) The possible role of tumor necrosis factor-alpha in diabetic polyneuropathy. Exp Diabesity Res 4: 65-71.
147. Schafers, M., Brinkhoff, J., Neukirchen, S., Marziniak, M. and Sommer, C. ( 2001) Combined epineurial therapy with neutralizing antibodies to tumor necrosis factor-alpha and interleukin-1 receptor has an additive effect in reducing neuropathic pain in mice. Neurosci Lett 310: 113-116.
148. Scheffler, N.M., Sheitel, P.L. and Lipton, M.N. ( 1991) Treatment of painful diabetic neuropathy with capsaicin 0.075%. J Am Podiatr Med Assoc 81: 288-293.
149. Schemmel, K.E., Padiyara, R.S. and D'Souza, J.J. ( 2009) Aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy: a review. J Diabetes Complications.
150. Schratzberger, P., Schratzberger, G., Silver, M., Curry, C., Kearney, M., Magner, M. et al (2000) Favorable effect of VEGF gene transfer on ischemic peripheral neuropathy. Nature Med 6: 405-413.
151. Schuessler, B. ( 2006) What do we know about duloxetine's mode of action? Evidence from animals to humans. BJOG 113: 5-9.
152. Schwartzman, R.J., Chevlen, E. and Bengtson, K. ( 2003) Thalidomide has activity in treating complex regional pain syndrome. Arch Intern Med 163: 1487-1488; author reply 1488.
153. Selvarajah, D., Gandhi, R., Emery, C.J. and Tesfaye, S. (2010) A randomised placebo controlled double blind clinical trial of cannabis based medicinal product (Sativex) in painful diabetic neuropathy: depression is a major confounding factor. Diabetes Care 33 (1): 128-130.
154. Sharma, S., Chopra, K. and Kulkarni, S.K. ( 2007) Effect of insulin and its combination with resveratrol or curcumin in attenuation of diabetic neuropathic pain: participation of nitric oxide and TNF-alpha. Phyto ther Res 21: 278-283.
155. Sharma, S. and Sharma, N. ( 2008) Epalrestat, an aldose reductase inhibitor, in diabetic neuropathy: An Indian perspective. Ann Indian Acad Neurol 11: 231-235.
156. Shay, K., Moreau, R., Smith, E., Smith, A. and Hagen, T. (2009) Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential. Biochim Biophys Acta 1790: 1149-1160.
157. Sheets, P.L., Heers, C., Stoehr, T. and Cummins, T.R. ( 2008) Differential block of sensory neuronal voltage-gated sodium channels by lacosamide, lidocaine and carbamazepine. J Pharmacol Exp Ther 326: 89-99.
158. Shrivastav, M. and Musley, S. (2009) Spinal cord stimulation for complex regional pain syndrome. Conf Proc IEEE Eng Med Biol Soc 1: 2033-2036.
159. Shweiki, D., Itin, A., Soffer, D. and Keshet, E. ( 1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359: 843-845.
160. Simpson, D.M., Brown, S. and Tobias, J. ( 2008) Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy. Neurology 70: 2305-2313.
161. Simpson, D.M., Estanislao, L., Brown, S.J. and Sampson, J. ( 2008) An open-label pilot study of high-concentration capsaicin patch in painful HIV neuropathy. J Pain Symptom Manage 35: 299-306.
162. Smith, A.G., Howard, J.R., Kroll, R., Ramachandran, P., Hauer, P., Singleton, J.R. et al (2005) The reliability of skin biopsy with measurement of intraepidermal nerve fiber density. J Neurol Sci 228: 65-69.
163. Smith, A.G., Russell, J., Feldman, E.L., Goldstein, J., Peltier, A., Smith, S. et al (2006) Lifestyle intervention for pre-diabetic neuropathy. Diabetes Care 29: 1294-1299.
164. Smith, A.G. and Singleton, J.R. ( 2008) Impaired glucose tolerance and neuropathy. Neurologist 14: 23-29.
165. Song, Z., Ultenius, C., Meyerson, B.A. and Linderoth, B. (2009) Pain relief by spinal cord stimulation involves serotonergic mechanisms: an experimental study in a rat model of mononeuropathy. Pain 147: 241-248.
166. Sorensen, L., Molyneaux, L. and Yue, D.K. ( 2006a) The level of small nerve fiber dysfunction does not predict pain in diabetic Neuropathy: a study using quantitative sensory testing. Clin J Pain 22: 261-265.
167. Sorensen, L., Molyneaux, L. and Yue, D.K. ( 2006b) The relationship among pain, sensory loss, and small nerve fibers in diabetes. Diabetes Care 29: 883-887.
168. Storkebaum, E., Diether, L. and Peter, C. ( 2004) VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection. BioEssays 26: 943-954.
169. Strickland, M.E. ( 1997) Evaluation of bacterial growth with occlusive dressing use on excoriated skin in the premature infant. Neonatal Netw 16: 29-35.
170. Sumner, C.J., Sheth, S., Griffin, J.W., Cornblath, D.R. and Polydefkis, M. ( 2003) The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology 60: 108-111.
171. Szallasi, A. and Blumberg, P.M. ( 1993) [3H]resiniferatoxin binding by the vanilloid receptor: species-related differences, effects of temperature and sulfhydryl reagents. Naunyn Schmiedebergs Arch Pharmacol 347: 84-91.
172. Szallasi, A. and Blumberg, P.M. ( 1999) Vanilloid (Capsaicin) receptors and mechanisms. Pharmacol Rev 51: 159-212.
173. Takei, Y. and Laskey, R. ( 2008) Interpreting crosstalk between TNF-alpha and NGF: potential implications for disease. Trends Mol Med 14: 381-388.
174. Tandan, R., Lewis, G.A., Krusinski, P.B., Badger, G.B. and Fries, T.J. ( 1992) Topical capsaicin in painful diabetic neuropathy. Controlled study with long-term follow-up. Diabetes Care 15: 8-14.
175. Tankova, T., Cherninkova, S. and Koev, D. ( 2005) Treatment for diabetic mononeuropathy with α-lipoic acid. Int J Clin Pract 59: 645-650.
176. Tavakoli, M., Kallinikos, P.A., Efron, N., Boulton, A.J. and Malik, R.A. ( 2007) Corneal sensitivity is reduced and relates to the severity of neuropathy in patients with diabetes. Diabetes Care 30: 1895-1897.
177. Tavakoli, M., Marshall, A., Pitceathly, R., Fadavi, H., Gow, D., Roberts, M.E. et al (2010) Corneal confocal microscopy: A novel means to detect nerve fibre damage in idiopathic small fibre neuropathy. Exp Neurol 223 (1): 245-250.
178. Tavakoli, M., Marshall, A., Thompson, L., Kenny, M., Waldek, S., Efron, N. et al (2009) Corneal confocal microscopy: a novel noninvasive means to diagnose neuropathy in patients with Fabry disease. Muscle Nerve 40: 976-984.
179. Tesfaye, S., Watt, J., Benbow, S.J., Pang, K.A., Miles, J. and MacFarlane, I.A. ( 1996) Electrical spinal-cord stimulation for painful diabetic peripheral neuropathy. Lancet 348: 1698-1701.
180. The Capsaicin Study Group (1991) Treatment of painful diabetic neuropathy with topical capsaicin. A multicenter, double-blind, vehicle-controlled study. Arch Intern Med 151: 2225-2229.
181. Topper, R., Foltys, H., Meister, I.G., Sparing, R. and Boroojerdi, B. ( 2003) Repetitive transcranial magnetic stimulation of the parietal cortex transiently ameliorates phantom limb pain-like syndrome. Clin Neurophysiol 114: 1521-1530.
182. Tremont-Lukats, I.W., Challapalli, V., McNicol, E.D., Lau, J. and Carr, D.B. ( 2005) Systemic administration of local anesthetics to relieve neuropathic pain: a systematic review and meta-analysis. Anesth Analg 101: 1738-1749.
183. Troy, T. ( 2002) The use of Opsite, Fixomull and Lycra ® in the management of diabetic neuropathic pain of the foot. Primary Intention 10: 162-164,166-170.
184. Turner, J.A., Deyo, R.A., Loeser, J.D., Von Korff, M. and Fordyce, W.E. ( 1994) The importance of placebo effects in pain treatment and research. JAMA 271: 1609-1614.
185. Uceyler, N., Rogausch, J.P., Toyka, K.V. and Sommer, C. ( 2007) Differential expression of cytokines in painful and painless neuropathies. Neurology 69: 42-49.
186. Uceyler, N. and Sommer, C. ( 2008) Cytokine regulation in animal models of neuropathic pain and in human diseases. Neurosci Lett 437: 194-198.
187. Umapathi, T., Tan, W.L., Loke, S.C., Soon, P.C., Tavintharan, S. and Chan, Y.H. ( 2007) Intraepidermal nerve fiber density as a marker of early diabetic neuropathy. Muscle Nerve 35: 591-598.
188. Valdivia, J.M., Dellon, A.L., Weinand, M.E. and Maloney Jr, C.T. ( 2005) Surgical treatment of peripheral neuropathy: outcomes from 100 consecutive decompressions. J Am Podiatr Med Assoc 95: 451-454.
189. Vileikyte, L., Peyrot, M., Gonzalez, J.S., Rubin, R.R., Garrow, A.P., Stickings, D. et al (2009) Predictors of depressive symptoms in persons with diabetic peripheral neuropathy: a longitudinal study. Diabetologia 52: 1265-1273.
190. Vincent, A.M., Hayes, J.M., McLean, L.L., Vivekanandan-Giri, A., Pennathur, S. and Feldman, E.L. (2009) Dyslipidemia-induced neuropathy in mice: the role of oxLDL/LOX-1. Diabetes 58: 2376-2385.
191. Vinik, A.I., Bril, V., Kempler, P., Litchy, W.J., Tesfaye, S., Price, K.L. et al (2005) Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial. Clin Ther 27: 1164-1180.
192. Wang, C.P., Kao, C.H., Chen, W.K., Lo, W.Y. and Hsieh, C.L. ( 2008) A single-blinded, randomized pilot study evaluating effects of electroacupuncture in diabetic patients with symptoms suggestive of gastroparesis. J Altern Complement Med 14: 833-839.
193. Weintraub, M.I., Herrmann, D.N., Smith, A.G., Backonja, M.M. and Cole, S.P. (2009) Pulsed electromagnetic fields to reduce diabetic neuropathic pain and stimulate neuronal repair: a randomized controlled trial. Arch Phys Med Rehabil 90: 1102-1109.
194. Weintraub, M.I., Wolfe, G.I., Barohn, R.A., Cole, S.P., Parry, G.J., Hayat, G. et al (2003) Static magnetic field therapy for symptomatic diabetic neuropathy: a randomized, double-blind, placebo-controlled trial. Arch Phys Med Rehabil 84: 736-746.
195. Wernicke, J.F., Pritchett, Y.L., D'Souza, D.N., Waninger, A., Tran, P., Iyengar, S. et al (2006) A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain. Neurology 67: 1411-1420.
196. Wiffen, P.J., Collins, S., McQuay, H.J., Carroll, D., Jadad, A. and Moore, R.A. ( 2010) Anticonvulsant drugs for acute and chronic pain. Cochrane Database Syst Rev 1: CD001133.
197. Wiggin, T.D., Sullivan, K.A., Pop-Busui, R., Amato, A., Sima, A.A. and Feldman, E.L. (2009) Elevated triglycerides correlate with progression of diabetic neuropathy. Diabetes 58: 1634-1640.
198. Wong, G.Y. and Gavva, N.R. (2009) Therapeutic potential of vanilloid receptor TRPV 1 agonists and antagonists as analgesics: recent advances and set-backs. Brain Res Rev 60: 267-277.
199. Wymer, J.P.M., Simpson, J.P., Sen, D.P., Bongardt, S.M.S. and on behalf of the Lacosamide, S.P. (2009) Efficacy and safety of lacosamide in diabetic neuropathic pain: an 18-week double-blind placebo-controlled trial of fixed-dose regimens. Clin J Pain 25: 376-385.
200. Yalcin, B.M., Karahan, T.F., Ozcelik, M. and Igde, F.A. ( 2008) The effects of an emotional intelligence program on the quality of life and well-being of patients with type 2 diabetes mellitus. Diabetes Educ 34: 1013-1024.
201. Yoshida, S., Hirai, M., Suzuki, S., Awata, S. and Oka, Y. (2009) Neuropathy is associated with depression independently of health-related quality of life in Japanese patients with diabetes. Psychiatry Clin Neurosci 63: 65-72.
202. Zelman, D.C., Brandenburg, N.A. and Gore, M. ( 2006) Sleep impairment in patients with painful diabetic peripheral neuropathy. Clin J Pain 22: 681-685.
203. Ziegler, D. ( 2008a) Painful diabetic neuropathy: treatment and future aspects. Diabetes Metab Res Rev 24(Suppl 1): S52-S57.
204. Ziegler, D. ( 2008b) Treatment of diabetic neuropathy and neuropathic pain: how far have we come? Diabetes Care 31(Suppl 2): S255-S261.
205. Ziegler, D., Ametov, A., Barinov, A., Dyck, P., Gurieva, I., Low, P. et al (2006) Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care 29: 2365-2370.
206. Ziegler, D., Nowak, H. and Low, P.A. ( 2004) Treatment of symptomatic diabetic polyneuropathy with the antioxidant α-lipoic acid: a meta-analysis. Diabet Med 21: 114-121.
207. Zin, C.S., Nissen, L.M., O'Callaghan, J.P., Duffull, S.B., Smith, M.T. and Moore, B.J. ( 2009) A randomized controlled trial of oxycodone vs placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin. J Pain, in press.
208. Zinman, L.H., Ngo, M., Ng, E.T., Nwe, K.T., Gogov, S. and Bril, V. ( 2004) Low-intensity laser therapy for painful symptoms of diabetic sensorimotor polyneuropathy: a controlled trial. Diabetes Care 27: 921-924.